|
|
Central nervous system (CNS) and peripheral nervous system (PNS) disorders in HIV-infected individuals may result from opportunistic infections, neoplasms and processes that appear to be primary effects of human immunodeficieny virus (HIV) itself. The nervous system may also be damaged as a result of the toxic effects of various treatments. Indeed, the majority of AIDS patients will eventually manifest one or more of these neurological conditions.
Opportunistic Infections & Neoplasms
|
Go to the HIVpositive.us Main Menu
Return to the Neurological Disorders Menu
REFERENCES:
Wolters P et al. The effects of dideoxyinosine (ddI) on the cognitive functioning of children with HIV infection after 6 and 10 months of treatment. VII Intl Conf AIDS, Florence. Vol 2: 194(W.B. 2051), 1991.
Yachoan R et al. Long term toxicity/activity profile of 2Õ,3Õ-dideoxyinosine in AIDS or AIDS-related complex. Lancet 336: 526-29, 1990.
Brouwers P et al. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr 117: 980-5, 1990.
De Girolami U et al. Neuropathology of the acquired immunodeficiency syndrome. Arch Pathol Lab Med 114: 643-655, 1990.
Gabuzda DH. Neurologic disorders associated with HIV infections. J Am Acad Dermatol 22: 1232-6, 1990.
Heyes, M P et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infecfion:
Relationship to clinical and neurological status. Ann Neurol 29(2): 202-9, Feb. 1991.
Ingraham L et al. Neuropsychological effects of early HIV-1 infection: assessment and methodology. J Neuropsych & Clin Neurosci 2: 174-182, 1990.
Kramer E et al. Brain imaging in acquired immunodeficiency syndrome dementia complex. Sem Nuc Med 20(4): 353-63, 1990.
Lechtenberg R. AIDS in thee brain. Intl J STD & AIDS 1: 311-317, 1990.
Lipton S. Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends in Neurosci, 15(3): 75-79, 1992.
Maj M. Organic mental disorders in HIV-1 infection. AIDS 4: 831-840, 1990.
McArthur J. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: Results from the Multicenter AIDS Cohort Study. Ann Neurol 26: 601-611, 1989.
McArthur J. Neurologic manifestations of AIDS. Medicine (66) 6: 407-437, 1987.
McGrail M et al. Peptide T studies: Neurophysiologic results. VII Ind Conf AIDS, Florence. Vol 1:194(M.B. 2049), 1991.
Mclntyre K et al. Pilot study of zidovudine (AZT) and zalcitabine (ddC) combination in HIV-associated dementia. Abstact #PBO 233, X Intl Conf AIDS, Yokohama, 1994.
Perdices M et al. Neuropsychological investigation of patients with AIDS and ARC.
J AIDS 3: 555-564, 1990.
Perry S. Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am J Psych 147(6): 696-710, 1990.
Portegies P. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. B Med J 299(6703): 819-21, 1989.
Price R et al. The brain in AIDS: Central nervous system HIV-1 infection and the AIDS dementia complex. Science 239: 586-92, 1988.
Price R et al. Central and peripheral nervous system complications of HIV-1 infecfion and AIDS. In: AIDS, Etiology, Diagnosis, Treatment and Prevention, eds. DeVita VT Hellman S and Rosenberg SA. J.B. Lippincott Company, Philadelphia, 3rd ed. 14:237-257, 1992.
Pullian L et al. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87(2): 503-12, Feb. 1991.
Satriano, J et al. Central nervous system stimulants as symptomatic treatment for AIDS dementia commplex. VII Intl Conf AIDS, Florence. Vol 1: 195 (M.B. 2053),1991.
Sidtis et al. Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial. Ann Neur 1993.
Simpson DM et al. Neurologic Manifestations of HIV Infection. Ann Intem Med 121: 769-785,1994.
Stover E et al. CNS effects of HIV-1 infecfion and AIDS in infants and children: A collaborative research agenda. Ped AIDS and HIV Infection 1: 109-119, Nov. 6, 1990.
Wiley C et al. Human immunodeficiency virus: infection of the nervous system. Curr Topics Microbiol 160: 157-72, 1990.
Worley IM et al. Clinical manifestations of the HIV-1 infection of the nervous system. In: Handbook of Neurovirology, W Stroop and R McKendall, eds. Marcel Dekker, 1992.
Worley JM et al. Management of neurologic complications of HIV-1 infection. In: The Medical Mmagement of AIDS, M Sande md P Volberding, eds. Philadelphia: W.B. Saunders Co., third edition. 13:193-217,1992.
Tozzi V et al. Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex. AIDS 7: 683-92, 1993.
OTHER REPORTS:
Aronow H et al. The management of the neurological complications of HIV infection and AIDS. AIDS 2(suppl 1): S 151-9, 1988.
Go to the Opportunistic Infections Menu
Go to the HIVpositive.us Main Menu